Reunion Neuroscience Inc.
PrivateLast Round
Series A
Extension
Sep 16, 2025
Est. Valuation
$13.1M
Total Funding Raised
$229.73M
Company Overview
Reunion Neuroscience Inc. is a biopharmaceutical company that develops psychedelic-inspired therapeutic solutions for underserved mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reunion Neuroscience Inc. Comps
Public and private peers based on sector, stage, and business model.
Reunion Neuroscience Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 16, 2025 | ||||
| Series A | May 2, 2024 | ||||
| Early Stage VC | Jan 25, 2024 | ||||
| Take Private | Aug 1, 2023 | ||||
| Corporate Funding | Nov 18, 2022 | ||||
Follow-on Offering | Mar 17, 2021 |
Key People
Founding team and executive leadership
Reunion Neuroscience Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Follow-on Offering |
| Chicago Atlantic BDC Advisers | Series A |
| Mitsui Global Investment | Series A, Series A Extension |
| Jennison Associates | Follow-on Offering |
| Bolt | Series A, Seed |
| MPM BioImpact | Series A, Take Private, Series A Extension |
| Plaisance Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2024
$103M round completed.
Reunion Neuroscience Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reunion Neuroscience Inc.'s valuation, stock price, and market status.
